The global leishmaniasis treatment market is gaining momentum as healthcare organizations, governments, and pharmaceutical companies intensify efforts to combat neglected tropical diseases. Leishmaniasis is a parasitic disease caused by protozoa of the Leishmania species and is transmitted through the bites of infected sandflies. The disease remains a significant public health concern in...

The global Vermox Market is poised for steady growth through 2034, driven by the increasing prevalence of parasitic worm infections, rising healthcare awareness, and expanding access to antiparasitic medications across developing and developed economies. Vermox, widely recognized for its effectiveness in treating intestinal worm infections such as pinworms, whipworms, roundworms, and hookworms,...